Actively Recruiting
Gynaecological Care for Transgender People in France in 2024.
Led by University Hospital, Bordeaux · Updated on 2026-01-15
500
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.
CONDITIONS
Official Title
Gynaecological Care for Transgender People in France in 2024.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- French-speaking transgender person (transgender women or transgender men)
- Age 18 years or older
You will not qualify if you...
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Haut-Lévêque
Pessac, France, 33604
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here